The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.
about
Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addictionThe selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in ratsEvidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in miceNeuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot studyCurrent perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.Addiction and brain reward and antireward pathways.Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in ratsThe dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference.Dopamine D3 receptor ligands for the treatment of tobacco dependence.Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration.Mechanism-based medication development for the treatment of nicotine dependence.The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats.PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in ratsUse of animal models to develop antiaddiction medications.The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesityEffects of nicotine in experimental animals and humans: an update on addictive propertiesVarenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humansEffects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model.Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders.Dopamine D3 receptor antagonists: a patent review (2007 - 2012).Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.Emerging therapeutic targets for the treatment of nicotine addiction.The dopamine D3 receptor, a quarter century later.The acute administration of the selective dopamine D(3) receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats.Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine.A Scutellaria baicalensis radix water extract inhibits morphine-induced conditioned place preference.Impulsive and compulsive behaviors in Parkinson's disease
P2860
Q28236375-5CE33D2B-74EF-4E86-A4FB-130DF031B4A3Q28256384-78752904-E784-41A8-A853-9CA8794DC449Q28296440-7DF3261A-5912-4A3C-AC19-CA00F5ADBC19Q30855960-E897B390-339D-48FC-AB80-68772683863CQ33992366-56910BBF-A003-47BB-85B7-1F3A3230EFD9Q34787576-6DBAEA19-1A77-4E13-91A6-57F57F1369AFQ35143623-AD81086B-D67F-46C9-9AF3-0127DF77F793Q35995170-6052FAF8-77A0-4780-AF5D-BE342E4161FAQ36431345-AF0F27F0-C72C-43B3-BA8C-4B50E11066DFQ36494884-7C87BC97-9CF5-4928-94F6-99B5257323AFQ36677397-7BFB9A08-9CE6-42D8-B3DC-BE0D0A4C3C33Q36850568-D4C71C2D-ECFA-4CFA-891F-7AE69202CA4FQ37018610-008EE963-AE73-49BB-9518-65C66C1FAE9FQ37052544-A6CEF3F6-2BE7-42EB-A305-FF5D35A9B0A5Q37057438-C946614A-97B5-4980-86D7-529D1E21DD33Q37060818-02779ACA-CD22-4D86-A543-710D888E8297Q37083099-8799C4FD-25E3-4305-9881-5BCDB8DD2DD2Q37189418-E75252D9-D268-4617-AC53-93A6AFA43C84Q37203879-EEDAC33E-8939-404F-91B5-DE724F9A7AE2Q37352862-A0C26E2D-A9B6-45FC-A18F-102B8E60907DQ37401673-E384E0DF-055A-464A-AF9B-99AC5ECE414DQ37409589-2A86CC57-BEDD-46CA-B58E-3A88E276B880Q37642452-E2A698A9-F96E-42E9-BFF4-F683498BDA7BQ38025028-F5393AEC-DEA2-45F0-AA08-D88B21BB9529Q38056059-FF6E711E-1ADA-4F44-90F5-3FE11911096AQ38071135-49F772C4-06EB-4750-87D4-A1C7A376F59DQ38173012-78EF52A6-438B-4C95-8637-9E1DE7781F85Q38335806-288ADE44-7959-487F-8775-A0C47F8125ACQ38473341-EE7EBEBC-1170-43E6-A7A2-C5CF364F6EF4Q38947750-A88B8228-8B2C-4083-8F4D-7C5D122E274FQ42050386-B1019BFB-8ED4-4E31-AAA4-D49FB0559D97Q42682263-A89F6CFE-8B08-4BB5-B1A9-F860575E162CQ50645631-AB1B61BB-6DD3-4B16-A604-2E342EB518CDQ58492844-7B8F19FC-A3A7-452E-B8C5-461E6820A0C9
P2860
The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The selective dopamine D3 rece ...... d environmental cue functions.
@en
The selective dopamine D3 rece ...... d environmental cue functions.
@nl
type
label
The selective dopamine D3 rece ...... d environmental cue functions.
@en
The selective dopamine D3 rece ...... d environmental cue functions.
@nl
prefLabel
The selective dopamine D3 rece ...... d environmental cue functions.
@en
The selective dopamine D3 rece ...... d environmental cue functions.
@nl
P2093
P2860
P1476
The selective dopamine D3 rece ...... d environmental cue functions.
@en
P2093
Arlene C Pak
Charles R Ashby
Christian A Heidbreder
Eliot L Gardner
Jeremy Gilbert
Maria Pilla
Zheng-Xiong Xi
P2860
P304
P356
10.1017/S1461145706006560
P577
2006-08-31T00:00:00Z